“Maybe the interim analysis of the mild-to-moder
Post# of 148179
(Total Views: 504)
Posted On: 05/22/2020 10:10:54 PM
Re: thriftycents #35093
“Maybe the interim analysis of the mild-to-moderate that NP has been talking about?”
My hope is that they won’t conduct an interim analysis of the mild/moderate trial as it wasn’t written into the trial design like the severe trial. The mild/moderate trial is close to being fully enrolled so I don’t see the benefit of doing so as even if it’s good, the FDA is still going to want full trial data.
My hope is that they won’t conduct an interim analysis of the mild/moderate trial as it wasn’t written into the trial design like the severe trial. The mild/moderate trial is close to being fully enrolled so I don’t see the benefit of doing so as even if it’s good, the FDA is still going to want full trial data.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼